New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-01

Study Completion Date

2018-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background and purpose. Even if periprocedural cerebral microembolism associated with carotid endarterectomy or stenting usually does not manifest as clinically overt stroke, neuropsychological disturbances resulting from these events represent an important clinical and socioeconomic problem. Still, it remains unclear whether the use proximal protection can lower the incidence of cerebral embolism associated with the treatment of carotid stenosis.

Materials and methods. This was a prospective randomised single-centre study, which was aimed at comparison of surgical eversion endarterectomy with stenting under proximal protection in symptomatic patients. The investigators evaluated the incidence of new ischaemic lesions revealed by the diffusion-weighted magnetic resonance imaging 2-4 days after the treatment and neurologic events.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physiological Magnetic Resonance Imaging (MRI) to Improve Carotid Endarterectomy Outcomes

NCT01272843

Carotid Stenosis Hypoperfusion Transient Ischemic Attack

UNKNOWN

Evaluation of Cerebrovascular Events in Patients With Occlusive Carotid Artery Disorders

NCT03840265

Carotid Stenosis Carotid Artery Plaque Cerebrovascular Embolism and Thrombosis

UNKNOWN NA

Endovascular Treatment and RIPC in Acute Ischemic Stroke

NCT04581759

Acute Ischemic Stroke Endovascular Treatment

UNKNOWN NA

Pragmatic Ischaemic Stroke Thrombectomy Evaluation

NCT01745692

Acute Ischaemic Stroke

TERMINATED NA

Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

NCT05983757

Ischemic Stroke

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The CARECarotid was a prospective randomised single-centre study, which was performed in the University Hospital in Kraków. It was planned to evaluate 50 patients presenting with symptomatic lesions of the internal carotid artery.

Patients were randomly assigned to one of the two treatment arms: surgical endarterectomy or carotid angioplasty with stenting under proximal protection. All patients provided their written informed consent to undergo the procedures and to participate in this trial.

In all surgical patients carotid endarterectomy will perform using the eversion technique. All surgical endarterectomies will perform under cervical block anaesthesia.

Perioperatively patients in the surgical arm received aspirin; other antiplatelet or anticoagulant agents were not administered during 5 days before surgery.

All procedures in carotid artery stenting will perform with proximal protection system - the Mo.Ma (Medtronic, Minneapolis, MN, USA) device. The investigators will implante stents that were tailored to the localisation of lesions and morphology of carotid arteries: Carotid Wallstent (Boston Scientific, Natick, MA, USA, and in patients with tortuous arteries Precise Pro RX (Cordis, Fremont, CA, USA) or Roadsaver (Terumo, Tokyo, Japan). Patients in the stent arm will receive clopidogrel 75 mg/day and aspirin 75 mg/day. These drugs were administered during 3 days before planned procedure and then 3-6 months after stent implantation. All patients will have MRI DWI performed before and 2-4 days after procedures in both groups. Within 6 months there will be an evaluation of the incidence of neurological events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carotid Artery Stenosis Carotid Atherosclerosis Stroke, Ischemic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients were randomly assigned to one of the two treatment arms: surgical endarterectomy or carotid angioplasty with stenting under proximal protection

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carotid Artery Stenting

Subjects will undergo carotid artery angioplasty and stenting with any CE-certificated carotid stent with a proximal protection system Mo.Ma

Group Type ACTIVE_COMPARATOR

Carotid Artery Stenting

Intervention Type PROCEDURE

Carotid artery stenting was considered successful if there was no residual stenosis greater than 20%, and there was no dissection of target artery following the procedure.

Endarterectomy carotid artery

Subjects will undergo carotid endarterectomy

Group Type ACTIVE_COMPARATOR

Endarterectomy carotid artery

Intervention Type PROCEDURE

Surgical endarterectomy was considered successful if there was no residual stenosis after procedure, without symptoms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Carotid Artery Stenting

Carotid artery stenting was considered successful if there was no residual stenosis greater than 20%, and there was no dissection of target artery following the procedure.

Intervention Type PROCEDURE

Endarterectomy carotid artery

Surgical endarterectomy was considered successful if there was no residual stenosis after procedure, without symptoms.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient's age ≥ 18 years;
* 60-99% stenosis of the internal carotid artery (degree of stenosis assessed by means of Doppler sonography, CT angiography or catheter angiography);
* diameter of the target internal carotid artery not more than 7 mm;
* symptomatic lesion (a history of ipsilateral stroke, transient ischaemic attack or reversible ischaemic neurological deficit);
* localisation and morphology of the lesion making possible surgical eversion endarterectomy or endovascular angioplasty with stent implantation;
* written informed consent.

Exclusion Criteria

* target lesion that has been previously stented;
* highly calcified lesions;
* very tortuous common and internal carotid arteries;
* occlusion of the contralateral carotid artery without adequate collateral circulation through the circle of Willis (revealed by means of transcranial Doppler sonography);
* anatomical contraindications for eversion endarterectomy;
* acute ipsilateral stroke;
* disabling stroke at any side;
* other severe pathologies of the brain resulting is significant loss of cerebral tissue and/or significant neurological deficits, such as extensive previous stroke or multiple lacunar infarcts;
* history of haemorrhagic transformation of ischaemic stroke;
* severe comorbidities (such as cancer or decompensated heart failure);
* allergy to aspirin, clopidogrel or ticlopidine;
* allergy to iodinated contrast media;
* pregnant women;
* women of reproductive age who do not use effective contraception;
* metallic implants (such as peacemakers and orthopaedic endoprostheses) or other known contraindications for magnetic resonance imaging;

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No